Trade Sale of Protected Networks GmbH to SolarWinds

Frankfurt, 16th November 2018. ACXIT Capital Partners exclusively advised software company Protected Networks GmbH and its shareholders on the trade sale to SolarWinds. Protected Networks, based in Berlin, is a leading provider of access rights management solutions in Europe under the brand name 8MAN. SolarWinds, headquartered in Austin, Texas (USA), is a leading provider of powerful and affordable IT infrastructure management software.
 

Weiter lesen

ORPEA’S POSITION IN PREMIUM NURSING HOMES IN GERMANY STRENGTHENED WITH ACQUISITION OF 7 FACILITIES AND SET-UP OF A DEDICATED JOINT VENTURE

Frankfurt, 7th November 2018. The ORPEA group, a world leader in long-term care (nursing homes, post-acute and rehabilitation hospitals, psychiatric hospitals, and homecare services), announced the acquisition of Axion group in Germany.

ACXIT Capital Partners, represented by Thomas Klack and his team, acted as exclusive financial advisor to ORPEA in this transaction. The parties agreed not to disclose any details of the transaction.

Weiter lesen

LISTED FRENCH SAAS COMPANY OXATIS ACQUIRES CHANNEL PILOT SOLUTIONS GMBH

Frankfurt, 6th November 2018. The publicly traded French Software as a Service (SaaS) company Oxatis is taking over Channel Pilot Solutions GmbH, with its product data management tool, to further extend its technological lead and accelerate growth in Europe. ACXIT Capital Partners (in cooperation with PAX Corporate Finance) acted as the exclusive M&A advisor to Channel Pilot Solutions GmbH and its shareholders.

Weiter lesen

ACXIT Capital Partners advises medpex on the trade sale of its e-commerce activities to Zur Rose Group

  • Link between mail-order activities of medpex and Zur Rose subsidiary DocMorris
  • Additional growth opportunities due to outstandingly complementary activities
  • The founders and managers of medpex will continue to lead the activities and will become shareholders in the Zur Rose Group AG

Ludwigshafen, 18 October 2018. medpex, the third biggest online pharmacy in Germany, is bundling its activities with Swiss company Zur Rose Group AG. With this step, medpex is setting the basis to continue its successful growth trajectory at a high pace in the future and play a proactive role in market consolidation. The outstandingly complementary activities of medpex and Zur Rose subsidiary DocMorris create additional growth opportunities for both companies. Customers will benefit from an even broader product range and from additional services. The founders and managers of medpex will also become shareholders in Zur Rose Group AG as part of the transaction.

Weiter lesen